Latest Breaking News On - Versant ventures - Page 7 : comparemela.com

Week In Review: 2024 Kicks Off With 3 Deals Worth A Total Of $4B

Week In Review: 2024 Kicks Off With 3 Deals Worth A Total Of $4B
seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.

United statesSan diegoSeattle umoja biopharmaFrazier life sciencesChina innovation centerBoehringer ingelheimRibo life scienceAvenzo therapeuticsMedilink therapeuticsAvistone biotechVivo capitalYanchuang capitalCathay capitalBain capitalWuxi apptecUmoja biopharma

SanReno Therapeutics Announces Acquisition by Novartis in Pivotal Transaction to Bring Forward Transformative Therapeutics in Kidney Disease

/PRNewswire/ SanReno Therapeutics, a clinical-stage company specializing in the discovery, development, and commercialization of innovative therapies for.

Haoyu huangFrazier life sciencesGreater chinaReno therapeuticsVenture partners chinaSamsara biocapitalVersant venturesChinook therapeuticsProliferation inducing ligandChief executive officer

Sanreno Therapeutics Announces Acquisition By Novartis In Pivotal Transaction To Bring Forward Transformative Therapeutics In Kidney Disease

Sanreno Therapeutics Announces Acquisition By Novartis In Pivotal Transaction To Bring Forward Transformative Therapeutics In Kidney Disease
menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.

Haoyu huangFrazier life sciencesGreater chinaReno therapeuticsVenture partners chinaSamsara biocapitalVersant venturesChinook therapeuticsProliferation inducing ligandChief executive officer

Graphite Bio: Reverse Merger Leading Into Big Special Dividend And Q2 Phase 3 Trial

Graphite Bio: Reverse Merger Leading Into Big Special Dividend And Q2 Phase 3 Trial
seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.

Graphite bioVersant venturesAlpha wave globalSamsara biocapitalSectoral asset management

858 Therapeutics Expands Leadership Team to Support Transition to the Clinic

Katherine Bell-McGuinn, M.D., Ph.D., joins as chief medical officer Company expects to initiate a Phase I clinical trial of its PARG inhibitor ETX-19477 in 2024 SAN DIEGO (BUSINESS WIRE) 858 Therapeutics is pleased to announce today that it has named Katherine Bell-McGuinn, M.D., Ph.D., as Chief Medical.

United statesSan diegoKatherine bell mcguinnEli lillyJeffrey staffordTexas lutheran universityMemorial sloan kettering cancer centerHead of oncology early developmentJohns hopkins university school of medicineChief medicalVice presidentOncology earlyJohns hopkins university schoolTexas lutheranVersant venturesCormorant asset management